A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults

Clinical trial NCT05636306 · COMPLETED

Trial details

NCT number: NCT05636306
Sponsor: NoNO Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke

Start date: 2022-11-22
Primary completion: 2023-10-05
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.